Showing 12,781 - 12,800 results of 224,509 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((greatest decrease) OR (largest decrease)) ))', query time: 1.01s Refine Results
  1. 12781

    Table_1_The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita.docx by Daniel L. Seiler (14137995)

    Published 2023
    “…Neutrophils lacking C5aR2 showed decreased activation after C5a stimulation and increased expression of the inhibitory Fcγ receptor FcγRIIb.…”
  2. 12782

    Image_2_The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita.jpg by Daniel L. Seiler (14137995)

    Published 2023
    “…Neutrophils lacking C5aR2 showed decreased activation after C5a stimulation and increased expression of the inhibitory Fcγ receptor FcγRIIb.…”
  3. 12783

    Image_1_The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita.tiff by Daniel L. Seiler (14137995)

    Published 2023
    “…Neutrophils lacking C5aR2 showed decreased activation after C5a stimulation and increased expression of the inhibitory Fcγ receptor FcγRIIb.…”
  4. 12784

    Table_1_Epigenetic Modulation of Class-Switch DNA Recombination to IgA by miR-146a Through Downregulation of Smad2, Smad3 and Smad4.pdf by Paolo Casali (489340)

    Published 2021
    “…Indeed, enforced miR-146a expression in B cells aborted induction of IgA CSR by decreasing Smad levels. …”
  5. 12785

    Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials by Tao Cheng (1235148)

    Published 2016
    “…The onabotulinumtoxinA-treated groups had a significantly decreased mean number of urinary incontinence episodes per week (at week 6) (onabotulinumtoxinA200U: MD: -10.72, 95% CI: -13.4 to -8.04, P<0.00001; 300 U: MD: -11.42, 95% CI: -13.91 to -8.93, P<0.00001), MDP (200 U: MD: -33.46, 95% CI: -39.74 to -27.18, P<0.00001; 300 U: MD: -31.72, 95% CI: -37.69 to -25.75, P<0.00001), and greater increased MCC (200 U: MD: 141.30, 95% CI: 121.28 to 161.32, P<0.00001; 300 U: MD: 151.39, 95% CI: 130.43 to 172.34, P<0.00001) compared to the placebo-treated groups. …”
  6. 12786
  7. 12787
  8. 12788
  9. 12789
  10. 12790

    SATB1 was a critical factor for the chromatin loop conversion and the cooperative expression of BCL2 and NOXA genes in Jurkat cells. by Yin Yang (35103)

    Published 2015
    “…<p>Jurkat cells were transiently transfected with control-shRNA or SATB1-shRNA plasmids, and targeting efficiency was confirmed by Western blot analysis (A). SATB1 knockdown significantly reduced the association of SATB1 with NOXA promoter (B), BCL2 promoter (C), and mbr (D), as revealed by q-ChIP. …”
  11. 12791
  12. 12792
  13. 12793
  14. 12794
  15. 12795
  16. 12796
  17. 12797

    The heuristics of nurse responsiveness to critical patient monitor and ventilator alarms in a private room neonatal intensive care unit by Rohan Joshi (4494667)

    Published 2017
    “…<div><p>Aim</p><p>Alarm fatigue is a well-recognized patient safety concern in intensive care settings. …”
  18. 12798
  19. 12799
  20. 12800